
“Elsewhere as we expected, Australia and New Zealand declined high single digit given the high comparative last year from COVID related demand,” said Tobias Hestler, chief financial officer during the webcast of the results. “China, our second largest market overall was up nearly 30 per cent following the easing of COVID related restrictions and subsequent rising cases. Gross profit was 1.84bn euros (US$2.03bn), up from 1.61bn euros (US$1.78bn) last year, while profit attributable to shareholders was up from 343m (US$379.04m) euros to 389m euros (US$429.87m).Ĭhina, the firm’s second largest market, has reported nearly 30 per cent revenue growth.

Haleon announced on May 3 that its Q1 revenue was up 13.7 per cent to hit 2.99bn euros (US$3.30bn). Revenue from Centrum was up high-single digit, which the firm said was “ due to strength in Asia Pacific, especially in China, South East Asia and Taiwan, and across Europe, Middle East, and Africa (EMEA).” Part of the contributing factor was due to successful consumer campaigns.Ĭaltrate, on the other hand, was also up high single digit, with good growth in China. The gut-brain axis: Psychobiotic opportunity in 25 countriese.Uncovering white spaces – Probiotics for a smooth menopause transition.Uncovering White Spaces – Probiotics for Pets.POSTbiotics – New Tools in Microbiome Modulation.After the pandemic: Business lessons and insights from 25 probiotic supplement e-markets.
